Verastem | VSTM - Equity Capital And Reserves


Verastem reported $-15.53M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -3.27B 628M Dec/2025
Alaunos Therapeutics USD 2.8M 858K Sep/2025
AstraZeneca USD 48.67B 2.78B Dec/2025
Curis USD -13.99M 7.38M Jun/2025
Cytokinetics USD -659.62M 138.5M Dec/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
Incyte USD 5.17B 516.28M Dec/2025
Laboratory Of America USD 8.62B 93.2M Dec/2025
Novartis USD 44.75B 2.7B Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
TG Therapeutics USD 648.02M 40.8M Dec/2025
Verastem USD -15.53M 16.91M Sep/2025